PRESS RELEASE published on 11/05/2024 at 06:30, 1 year 3 months ago Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October. Redcare Pharmacy reports strong Q3 growth with 2% adj. EBITDA margin. Rx sales surge by over 130% in Germany. Total Group sales up 21% in Q3 to EUR 575M EBITDA Margin Germany Redcare Pharmacy Rx Sales Q3 Growth
BRIEF published on 10/03/2024 at 22:06, 1 year 4 months ago Redcare Pharmacy Reports Significant Growth in Q3 Rx Sales Customer Base Expansion Rx Sales Growth E-Rx Metrics Marketing Investment Non-Rx Sales
BRIEF published on 10/03/2024 at 22:06, 1 year 4 months ago Redcare Pharmacy rapporte une croissance significative des ventes de médicaments sur ordonnance au troisième trimestre Croissance Des Ventes De Médicaments Sur Ordonnance Mesures E-Rx Investissement En Marketing Ventes Sans Ordonnance Élargissement De La Clientèle
BRIEF published on 10/03/2024 at 22:02, 1 year 4 months ago Redcare Pharmacy Announces Significant Growth in German Rx Sales for Q3 Financial Guidance Germany Redcare Pharmacy Rx Sales Growth E-Rx Metrics
BRIEF published on 10/03/2024 at 22:02, 1 year 4 months ago Redcare Pharmacy annonce une croissance significative des ventes de médicaments sur ordonnance en Allemagne au troisième trimestre Allemagne Pharmacie Redcare Orientation Financière Croissance Des Ventes De Médicaments Sur Ordonnance Métriques E-Rx
PRESS RELEASE published on 10/03/2024 at 22:01, 1 year 4 months ago Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics. Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany and 108% in September, leading to accelerated marketing efforts based on strong e-Rx metrics. Full-year 2024 guidance updated for increased marketing activity Sales Growth Redcare Pharmacy Q3 E-Rx Metrics Marketing Acceleration
PRESS RELEASE published on 10/03/2024 at 21:57, 1 year 4 months ago EQS-Adhoc: Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated. Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September. Full-year guidance updated with strategic decision to accelerate marketing in Q4 based on convincing e-Rx metrics Marketing Germany Redcare Pharmacy Full-year Guidance Q3 Sales
BRIEF published on 07/30/2024 at 06:35, 1 year 6 months ago Redcare Pharmacy Reports Robust Q2 Growth and Steady Profit Margins EBITDA Customer Base Prescription Sales DACH Region Q2 Growth
BRIEF published on 07/30/2024 at 06:35, 1 year 6 months ago Redcare Pharmacy annonce une croissance robuste au deuxième trimestre et des marges bénéficiaires stables BAIIA Ventes Sur Ordonnance Clientèle Croissance Au Deuxième Trimestre Région DACH
PRESS RELEASE published on 07/30/2024 at 06:30, 1 year 6 months ago Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin. Redcare Pharmacy N.V. achieves rapid growth in Rx sales in Germany, with strong overall performance and 2.7% Q2 margin Financial Results Germany Growth Rate Redcare Pharmacy N.V. Rx Sales
Published on 02/21/2026 at 00:45, 6 hours 56 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 7 hours 11 minutes ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 8 hours 41 minutes ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 9 hours 24 minutes ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/20/2026 at 18:36, 13 hours 5 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 13 hours 10 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 13 hours 41 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 13 hours 41 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 12 hours 12 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 12 hours 12 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 13 hours 41 minutes ago TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 13 hours 41 minutes ago TERACT - Résiliation du contrat de liquidité